Valuation: NIOX Group Plc

Market Cap 273M 361M 327M 302M 514M 34B 532M 3.63B 1.44B 18.16B 1.35B 1.32B 57.66B P/E 2026 *
31.2x
P/E 2027 * 21.8x
Enterprise Value 245M 324M 294M 272M 462M 30.55B 478M 3.26B 1.29B 16.32B 1.22B 1.19B 51.8B EV / Sales 2026 *
4.85x
EV / Sales 2027 * 4.4x
Free-Float
78.35%
Yield 2026 *
2.84%
Yield 2027 * 3.21%
1 day+1.25%
1 week+1.25%
Current month-4.14%
1 month-4.42%
3 months-4.14%
6 months+5.54%
Current year-2.41%
1 week 62
Extreme 62
66
1 month 60.89
Extreme 60.8941
80
Current year 53.84
Extreme 53.84
80
1 year 53.84
Extreme 53.84
80
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 15/01/2025
Director of Finance/CFO - 13/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 07/02/2018
Director/Board Member - 01/09/2019
Chairman 73 04/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/05/26 Buy

Chief Financial Officer

34,127 0.0081%
29/05/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/05/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+1.25%-6.90%-1.82% 361M
+1.26%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
-0.44%+3.69%+41.45%+70.04% 386B
+0.55%+0.70%+59.02%+45.79% 364B
-0.12%+0.74%+28.39%+60.32% 302B
+0.37%+0.37%+3.33%+38.57% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average +0.36%+1.99%+31.16%+75.92% 429B
Weighted average by Cap. +0.54%+3.26%+37.69%+99.28%

Financials

2026 *2027 *
Net sales 50.48M 66.74M 60.48M 55.94M 95.12M 6.29B 98.47M 672M 266M 3.36B 250M 245M 10.67B 54.46M 72.01M 65.25M 60.35M 103M 6.79B 106M 725M 287M 3.63B 270M 264M 11.51B
Net income 9.25M 12.23M 11.08M 10.25M 17.43M 1.15B 18.05M 123M 48.83M 616M 45.9M 44.93M 1.96B 12.15M 16.06M 14.55M 13.46M 22.89M 1.51B 23.69M 162M 64.12M 809M 60.27M 58.99M 2.57B
Net Debt -27.71M -36.64M -33.2M -30.71M -52.22M -3.45B -54.06M -369M -146M -1.85B -138M -135M -5.86B -33.07M -43.73M -39.63M -36.65M -62.32M -4.12B -64.52M -440M -175M -2.2B -164M -161M -6.99B
Projected Income Statement - Annual - NIOX Group Plc
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
13/11/26 GBX 64.80 +1.25% 176,572
12/11/26 GBX 64.00 +0.63% 314,776
11/11/26 GBX 63.60 -1.24% 189,363
10/11/26 GBX 64.40 0.00% 194,476
09/11/26 GBX 64.40 +0.63% 3,468,392
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - NIOX Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.6480GBP
Average target price
0.8240GBP
Spread / Average Target
+27.16%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - NIOX Group Plc